实用中医药杂志
實用中醫藥雜誌
실용중의약잡지
JOURNAL OF PRACTICAL TRADITIONAL CHINESE MEDICINE
2015年
6期
485-486
,共2页
中度淤胆型肝炎%中药%对照治疗观察
中度淤膽型肝炎%中藥%對照治療觀察
중도어담형간염%중약%대조치료관찰
Moderate cholestatic hepatitis%Chinese herbs%control treatment and observation
目的：观察中药治疗中度淤胆型肝炎的疗效。方法：121例随机分为研究组63例和对照组58例，研究组用中药治疗，对照组用西药治疗。结果：治疗后研究组肝功能指标明显优于对照组（P＜0.05）。总有效率研究组76.2%，对照组62.1%，两组比较差异有统计学意义（P＜0.05）。腹泻、乏力、黄疸、皮肤瘙痒、肝区不适总有效率研究组分别为82.2%、81.0%、77.8%、84.8%和80.3%，对照组分别为69.5%、68.9%、63.8%、71.9%和62.5%，两组比较差异有统计学意义（P＜0.05）。结论：中药治疗中度淤胆型肝炎疗效显著，且无明显不良反应。
目的：觀察中藥治療中度淤膽型肝炎的療效。方法：121例隨機分為研究組63例和對照組58例，研究組用中藥治療，對照組用西藥治療。結果：治療後研究組肝功能指標明顯優于對照組（P＜0.05）。總有效率研究組76.2%，對照組62.1%，兩組比較差異有統計學意義（P＜0.05）。腹瀉、乏力、黃疸、皮膚瘙癢、肝區不適總有效率研究組分彆為82.2%、81.0%、77.8%、84.8%和80.3%，對照組分彆為69.5%、68.9%、63.8%、71.9%和62.5%，兩組比較差異有統計學意義（P＜0.05）。結論：中藥治療中度淤膽型肝炎療效顯著，且無明顯不良反應。
목적：관찰중약치료중도어담형간염적료효。방법：121례수궤분위연구조63례화대조조58례，연구조용중약치료，대조조용서약치료。결과：치료후연구조간공능지표명현우우대조조（P＜0.05）。총유효솔연구조76.2%，대조조62.1%，량조비교차이유통계학의의（P＜0.05）。복사、핍력、황달、피부소양、간구불괄총유효솔연구조분별위82.2%、81.0%、77.8%、84.8%화80.3%，대조조분별위69.5%、68.9%、63.8%、71.9%화62.5%，량조비교차이유통계학의의（P＜0.05）。결론：중약치료중도어담형간염료효현저，차무명현불량반응。
Objective: To observe the therapeutic effect on moderate cholestatic hepatitis treated by Chinese herbs. Method: 121 cases were divided into 2 groups randomly.63 cases were treated by Chinese herbs as the study group while 58 cases were treated by western medicine as the control group. Result: After the treatment, the liver function indexes of the study group was superior to that of the control group significantly(P<0.05). The total effective rate of the study group was 76.2% while that of the control group was 62.1%. There was significant difference between the two groups (P<0.05).The total effective rate of improvement of diarrhea, hypodynamia, jaundice, pruritus, uncomfortable of hepatic region of the study group was 82.2%, 81.0%,77.8%,84.8% and 80.3% respectively while that of the control group was 69.5%,68.9%,63.8%,71.9% and 62.5% respectively.There were significant differences between the two groups(P<0.05). Conclusion: Chinese herbs have significant therapeutic effect on moderate cholestatic hepatitis without adverse reaction.
